Track LNSR and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
LENSAR Inc
2800 Discovery Drive, Orlando, FL, United States, 32826
IPO
2020
Employees
150
Industry
Medical Devices
Sector
Healthcare
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Insider Transactions
Quarterly buy vs. sell activity
Sell (left)Buy (right)
Q3 20240+8
8
Q4 20230+3
3
Q3 20230+1
1
Q2 20230+3
3
4-quarter cumulative
0 sells15 buys
Analyst Ratings
2 analysts covering
Hold100%recommend hold
Buy
0
Hold
2
Sell
0